Summary: Exela is a global business process automation company with operations in the United States,
Summary: Acadia reported solid earnings for Q3, 2021 despite COVID-19 headwind lashing its Parkinson’s Disease
Summary: Aadi Bioscience receives FDA approval of Fyarro for treatment of patients with PEComa. Fyarro
Summary: 360 DigiTech has reported strong third-quarter results, with both turnover and net income posting
Summary: As seen by Exela’s topline, not all digital transformation plays have been able to
Summary: Today, we revisit a small developmental firm called Zynerba Pharmaceuticals. The company is advancing
Summary: Affimed reported mixed Q2 earnings that revealed more milestone payments from their partnerships. In
Summary: Cyngn has filed proposed terms for a $30 million IPO. The firm is developing
Summary: I’ve compared 360 DigiTech’s financials with its four most important peers. Based on the
Summary: Cyngn has filed to raise $35 million in an IPO from the sale of